文献速递肺结节与肺癌肺栓塞与肺血管病

肺内皮miR-1调控肿瘤生长与血管生成

Lung Endothelial MicroRNA-1 Regulates Tumor Growth and Angiogenesis.
PubMed 文献 · Am J Respir Crit Care Med · 2017-01-01

本研究探讨miR-1在非小细胞肺癌(NSCLC)中的临床意义及其在肿瘤内皮中的特异性作用。发现NSCLC患者肿瘤组织及肿瘤内皮细胞中miR-1水平降低,且与总生存相关;血管特异性过表达miR-1可减少小鼠肿瘤负荷、生长和血管密度,其作用通过PI3K调控及靶向MPL实现。

要点

  • NSCLC肿瘤及肿瘤内皮中miR-1水平降低,与患者总生存相关。
  • 血管特异性过表达miR-1可减轻小鼠肿瘤负荷和血管生成。
  • miR-1通过PI3K调控内皮增殖并靶向MPL控制肿瘤进展。

核心结论

  • 内皮miR-1在NSCLC肿瘤中下调,并控制肿瘤进展和血管生成。

研究设计与样本

  • 研究采用Taqman法检测miR-1水平,磁珠分选内皮细胞,构建血管特异性miR-1慢病毒载体和诱导型转基因小鼠。
  • 使用KRASG12D mut/Trp53-/-(KP)小鼠、肺特异性VEGF转基因小鼠、Lewis肺癌异种移植和原代内皮细胞测试miR-1效应。

主要发现

  • 在两个NSCLC患者队列中,肿瘤组织miR-1水平低于无癌组织,且肿瘤miR-1水平与患者总生存相关。
  • 从NSCLC肿瘤和KP小鼠荷瘤肺分离的内皮细胞中miR-1水平也降低。
  • 载体介导或转基因过表达内皮miR-1可减少KP小鼠肿瘤负荷、降低Lewis肺癌异种移植生长和血管密度、减少VEGF转基因小鼠气管血管生成。
  • 内皮细胞中miR-1水平通过磷脂酰肌醇3-激酶调控,并特异性控制增殖、DNA从头合成和ERK1/2活化。
  • 髓增殖性白血病癌基因(MPL)是肺内皮中miR-1的靶点,调控肿瘤生长和血管生成。

临床怎么用

  • 内皮miR-1水平可能作为NSCLC预后相关标志物。
  • 靶向内皮miR-1或其下游通路可能成为抗肿瘤血管生成策略。

局限性

  • 研究主要基于动物模型和体外细胞实验,临床转化需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: Vascular endothelial growth factor down-regulates microRNA-1 (miR-1) in the lung endothelium, and endothelial cells play a critical role in tumor progression and angiogenesis. OBJECTIVES: To examine the clinical significance of miR-1 in non-small cell lung cancer (NSCLC) and its specific role in tumor endothelium. METHODS: miR-1 levels were measured by Taqman assay. Endothelial cells were isolated by magnetic sorting. We used vascular endothelial cadherin promoter to create a vascular-specific miR-1 lentiviral vector and an inducible transgenic mouse. KRASG12D mut/Trp53-/- (KP) mice, lung-specific vascular endothelial growth factor transgenic mice, Lewis lung carcinoma xenografts, and primary endothelial cells were used to test the effects of miR-1. MEASUREMENTS AND MAIN RESULTS: In two cohorts of patients with NSCLC, miR-1 levels were lower in tumors than the cancer-free tissue. Tumor miR-1 levels correlated with the overall survival of patients with NSCLC. miR-1 levels were also lower in endothelial cells isolated from NSCLC tumors and tumor-bearing lungs of KP mouse model. We examined the significance of lower miR-1 levels by testing the effects of vascular-specific miR-1 overexpression. Vector-mediated delivery or transgenic overexpression of miR-1 in endothelial cells decreased tumor burden in KP mice, reduced the growth and vascularity of Lewis lung carcinoma xenografts, and decreased tracheal angiogenesis in vascular endothelial growth factor transgenic mice. In endothelial cells, miR-1 level was regulated through phosphoinositide 3-kinase and specifically controlled proliferation, de novo DNA synthesis, and ERK1/2 activation. Myeloproliferative leukemia oncogene was targeted by miR-1 in the lung endothelium and regulated tumor growth and angiogenesis. CONCLUSIONS: Endothelial miR-1 is down-regulated in NSCLC tumors and controls tumor progression and angiogenesis.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Korde A, Jin L, Zhang JG, et al. Lung Endothelial MicroRNA-1 Regulates Tumor Growth and Angiogenesis. Am J Respir Crit Care Med. 2017. PMID: 28853613. doi:10.1164/rccm.201610-2157OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。